Keros Therapeutics (KROS) Other Working Capital Changes (2019 - 2025)

Keros Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$770000.0 for Q3 2025.

• Quarterly Other Working Capital Changes changed N/A year-over-year to -$770000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $155000.0 (changed N/A YoY) and the FY2021 annual result came in at -$62000.0, up 83.51% from the prior year.
• Other Working Capital Changes was -$770000.0 for Q3 2025 at Keros Therapeutics, up from -$2.4 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $10.8 million in Q2 2024 and bottomed at -$11.3 million in Q3 2024.
• A 5-year average of $1.1 million and a median of -$287000.0 in 2022 frame the typical range for Other Working Capital Changes.
• Peak annual rise in Other Working Capital Changes reached 2780.0% in 2022, while the deepest fall reached 2580.0% in 2022.
• Keros Therapeutics' Other Working Capital Changes stood at -$16000.0 in 2021, then jumped by 2612.5% to $402000.0 in 2022, then tumbled by 291.54% to -$770000.0 in 2025.
• Business Quant data shows KROS's Other Working Capital Changes at -$770000.0 in Q3 2025, -$2.4 million in Q2 2025, and $3.3 million in Q1 2025.